Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Health and Life Sciences at the Edge: Advancements in Medical Imaging Processing

“One of the major reasons for the rapid growth of the medical imaging market is the large number of technical improvements in both hardware and software.” – Beenish Zia In this episode of Health and Life Sciences at the Edge, host Tyler Kern speaks with Beenish Zia, an electrical engineer working as a platform…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

“One of the major reasons for the rapid growth of the medical imaging market is the large number of technical improvements in both hardware and software.” – Beenish Zia

In this episode of Health and Life Sciences at the Edge, host Tyler Kern speaks with Beenish Zia, an electrical engineer working as a platform architect in Health and Life Sciences at Intel, and Joy Yun, who interned in Health and Life Sciences at Intel, about the technological advances fueling the rapid expansion of the medical imaging industry.

The U.S. Food and Drug Administration defines medical imaging as several different technologies used to view the human body to diagnose, monitor, or treat medical conditions. Each type of technology gives different types of information about the area of the body being studied or treated. Examples include Ultrasound, X-ray, magnetic resonance imaging (MRI), and computer tomography (CT).

According to a market insights report by Research and Markets, the global medical imaging market size is expected to reach $28.6 billion by 2028. Zia attributes this rapid growth to advances in medical imaging hardware and software. “These advances include a variety of technical improvements,” says Zia, “from the devices that generate the raw data to how data is processed, stored, and transferred before it can be viewed by a radiologist or a healthcare technician.”

Three specific developments are driving advances in medical image processing:

  • Convolutions and Cross-correlations: Software processes used to identify issues and refine, adjust, or modify image quality.
  • Parallel Programming: Allows the effective distribution of workloads over the computational resources available.
  • oneAPI Implementation: oneAPI is a cross industry, open standards-based, unified programming model that allows developers to write code in a common language, thereby enabling companies to code without having to learn three or more language constructs. “I believe oneAPI will provide developers with faster application performance, more productivity, and hopefully greater innovation effect,” says Yun.

According to Zia, another major advantage to using oneAPI, including Intel’s oneAPI implementation, is that it has the potential to end hardware-vendor lock-in. “Historically, when developers needed to move their application to a new hardware or target device based on a different architecture than what they were using, they would have to create an entirely new code base,” says Zia. “Those extra costs and delays are never welcome.” The goal of Intel’s oneAPI implementation is threefold:

  • Increase application portability
  • Raise developer productivity
  • Deliver peak performance to high-growth applications in data centers, at the Edge, and in the Cloud.

To learn more:

If you are a developer interested in using oneAPI, visit “oneAPI: A New Era of Heterogeneous Computing: https://www.intel.com/content/www/us/en/developer/tools/oneapi/overview.html#gs.fgsjop

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Get  checked out

Get checked out

Seeking medical evaluation immediately after a vehicle crash, regardless of how you feel, is essential because adrenaline can mask serious injuries for hours or even up to a full day. A same-day medical visit creates a documented paper trail tied to the accident date, which protects against insurance companies disputing injury claims and denying compensation.

  • 01Feeling fine immediately after a vehicle crash may not accurately reflect one's health condition.
  • 02The body's response to stress can delay the onset of injury symptoms.
  • 03Seek medical evaluation after a crash, even if injuries aren't immediately apparent.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512